The European Brain Council is a non-profit organization dedicated to promoting brain research and improving the lives of the estimated 179 million Europeans living with brain conditions. Here, they discuss efforts aimed at enhancing care and raising awareness about brain health in Europe.
A new project is expected to help us understand diseases such as cancer and dementia. A major partnership involving Oxford Nanopore Technologies, UK Biobank, NHS England, Genomics England, and the UK government has made this possible.
Dementia is the leading cause of death in the UK, having a huge impact on people living with the condition, their families and the health systems supporting them. We hear from Dementia UK’s Andrew Pike, Head of Policy, Campaigns and Public Affairs, about how the UK Government can help to alleviate these pressures, most notably through aiding specialist nursing support.
Jules Knight, Consultant Admiral Nurse for Young Onset Dementia at Dementia UK, tells us about the prevalence of young onset dementia and some of the challenges that people living with dementia can face.
A second groundbreaking drug for Alzheimer's disease has been rejected for widespread use by the NHS in England; according to the drugs spending watchdog, the drug known as Donanemab does not offer sufficient value for money.
Dhivya Venkat, CEO & Co-Founder of Esya Inc., discusses the urgent need for integrating innovative diagnostics and therapies into the NHS in order to improve dementia care and diagnosis.
According to the World Health Organization (WHO), dementia is the third leading cause of mortality in Europe and the seventh globally, with a societal cost in Europe estimated to be €392bn in 2019. By 2025, 9.1 million people will be living with dementia in the European Union, rising to 14.3 million in 2050. We discuss dementia care provision with Alzheimer Europe.
Cambridge Vision Technology utilises AI-based technology to detect Alzheimer’s disease early on by using ocular biomarkers. They emphasise the importance of early detection of dementia to improve clinical outcomes for disease therapies and to maximise the economic and societal impact of this innovative new technology.
Quantified Imaging, originating from the University of Nottingham, specialises in advanced MRI techniques to improve dementia care, diagnosis, monitoring, and treatment.
Researchers at Queen Mary University of London have made a significant breakthrough in the early prediction of dementia, developing a new method that can predict the disease with over 80% accuracy up to nine years before a clinical diagnosis.
Researchers have found a new method to distinguish between Dementia with Lewy Bodies (DLB) and Alzheimer's Disease (AD) using vocal emotional expressions.
A recent study led by the Molecular and Cellular Neurobiotechnology group at the Institute for Bioengineering of Catalonia (IBEC) and the University of Barcelona...
People living with dementia are a hugely underserved group in so many ways, but dementia-supporting technology can offer better and longer independent living; Fiona Carragher, Director of Research and Influencing at Alzheimer’s Society, explains how.
A study has revealed that a 1 % decrease in deep sleep each year among individuals aged 60 and older can lead to a 27 % rise in the risk of developing dementia.
